Access keys:
Eidgenössische Ethikkommission für die Biotechnologie im Ausserhumanbereich EKAH
Federal Ethics Committee on Non-Human Biotechnology ECNH
-»This version is meant for browsers without CSS support mainly for visually disabled users. For a more advanced layout please use a more recent browser like Firefox 2.0 or Internet Explorer 7.«-
News
New publications in the ECNH book series "Contributions to Ethics an Biotechnology"
Helmut Segner, Fish. Nociception and pain - A biological perspective, 2012, Volume 9.
Markus Wild, Fische. Kognition, Bewusstsein und Schmerz - Eine philosophische Perspektive, 2012, Volume 10.
Release of genetically modified plants - ethical requirements
There is little argument that releasing genetically modified plants involves risks. Opinion varies on what these risks are and what their consequences might be. What requirements should be imposed on the experimental and commercial release of such plants from and ethical standpoint, and in particular with regard to the ethics of risks?
Release of genetically modified plants - ethical requirements (2 MB), Report, August 2012.
Acitivity Report
About us
The Federal Ethics Committee on Non-Human Biotechnology (ECNH) was appointed by the Federal Council to advise the authorities from an ethical perspective, as an independent expert committee, in the field of non-human biotechnology and gene technology.
